To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

June 17, 2019___

Today's Rundown

Featured Story

UniQure weighs sale after hemophilia gene therapy turnaround: report

Gene therapy specialist uniQure is considering selling up amid interest from large pharma buyers, according to Bloomberg. The report follows the revitalization of uniQure’s hemophilia B prospect and accompanying triple-digit stock price surge.

Top Stories

AstraZeneca commits $630M to Korean drug R&D push

AstraZeneca is set to spend $630 million on R&D in South Korea over the next five years. The commitment is part of a wider agreement between organizations in Korea and Sweden. 

Celgene hands PD-1 tislelizumab med back to BeiGene, forfeiting $150M

Barely two years after forking over $263 million up front for the ex-Asia rights to BeiGene’s PD-1 drug, Celgene is bowing out—and paying a $150 million termination fee to do it.

Medicines Company executive jumps ship to Scynexis

Antifungal specialist Scynexis has nabbed Nkechi Azie as its vice president of clinical development from her role as infectious disease head at The Medicines Company.

The top 20 drugs by 2018 U.S. sales

Using corporate financial statements and annual earnings transcripts, FiercePharma has put together its list of the top 20 drugs by 2018 U.S. sales.

Resources

[Whitepaper] Satisfying GxP Requirements Using the Internet of Things (IoT)

How can the Internet of Things (IoT) enable you to meet GxP?

[Whitepaper] Managing Comorbidities in Type 2 Diabetes – Real World Evidence for Change

Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities.

[Webinar] Why do US sponsors come to Russia? New options for clinical trials.

Fast and cost-efficient patient-enrollment,100% success strategy for obtaining a CTA, unified market authorization across the EEU countries. Find out the key compelling reasons to conduct studies in Russia.

[Whitepaper] Agile Competitive Intelligence Strategies For Healthcare

What is agile competitive intelligence, and how can it help take market research to the next level?

[POCKET GUIDE] Reference and Literature Management Made Easy

Get 5 quick tips for faster research and better results!

[Report] Precision medicine from concept to clinic

In this publication, Blue Latitude Health maps the journey of stakeholders impacted by the rise of precision medicine today. Download the report.

[Whitepaper] Flow Chemistry: A Scale-Up Solution for Modern API Development & Manufacturing

Increase Safety & Flexibility with Flow Chemistry

[On-Demand Webinar] Lessons Learned Implementing an End-to-End RIM Solution

IONIS shares best practices for implementing an end-to-end RIM solution in this on-demand webinar. Watch now.

[Whitepaper] Site-specific, Patient-centered and Whip-smart: Enrollment Assistants Adapt to a Shifting Landscape

Increasingly complex clinical trials place a tremendous burden on study sites, exacerbating already-troubling recruitment and enrollment issues. Overwhelmed, many sites may not be up to the task or have the appropriate infrastructure, creating costly delays that keep new therapies from patients.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events